SB continues research aimed at discovering new chemokine receptor antagonists May 31, 2000 No Comments
Repifermin shows positive results in phase II trial as treatment of chronic venous ulcers May 26, 2000 No Comments
Selective RXR agonists designed at Allergan particularly useful for skin-related diseases May 19, 2000 No Comments
Ligand releases new data confirming Ontak's effectiveness in patients with severe psoriasis May 15, 2000 No Comments
Eisai investigates selective RARalpha agonists for dermatologic, immunologic disorders May 11, 2000 No Comments
RSS